Atria Investments’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.48M | Sell |
6,769
-471
| -7% | -$103K | 0.02% | 856 |
|
2025
Q1 | $1.62M | Sell |
7,240
-1,428
| -16% | -$320K | 0.02% | 788 |
|
2024
Q4 | $2.84M | Sell |
8,668
-406
| -4% | -$133K | 0.04% | 548 |
|
2024
Q3 | $2.72M | Buy |
9,074
+1,475
| +19% | +$443K | 0.03% | 567 |
|
2024
Q2 | $2.5M | Sell |
7,599
-436
| -5% | -$144K | 0.03% | 569 |
|
2024
Q1 | $3.18M | Sell |
8,035
-617
| -7% | -$244K | 0.04% | 485 |
|
2023
Q4 | $3.05M | Sell |
8,652
-1,119
| -11% | -$394K | 0.05% | 442 |
|
2023
Q3 | $3.67M | Buy |
9,771
+338
| +4% | +$127K | 0.07% | 361 |
|
2023
Q2 | $3.61M | Buy |
9,433
+157
| +2% | +$60K | 0.07% | 358 |
|
2023
Q1 | $3.21M | Buy |
9,276
+669
| +8% | +$232K | 0.06% | 374 |
|
2022
Q4 | $2.03M | Buy |
8,607
+2,589
| +43% | +$609K | 0.04% | 505 |
|
2022
Q3 | $1.48M | Sell |
6,018
-913
| -13% | -$225K | 0.03% | 584 |
|
2022
Q2 | $2.1M | Sell |
6,931
-7,271
| -51% | -$2.2M | 0.04% | 493 |
|
2022
Q1 | $5.83M | Buy |
14,202
+421
| +3% | +$173K | 0.1% | 234 |
|
2021
Q4 | $6.46M | Buy |
13,781
+1,154
| +9% | +$541K | 0.12% | 215 |
|
2021
Q3 | $5.36M | Buy |
12,627
+1,835
| +17% | +$779K | 0.1% | 230 |
|
2021
Q2 | $3.88M | Sell |
10,792
-493
| -4% | -$177K | 0.07% | 300 |
|
2021
Q1 | $3.18M | Buy |
11,285
+6,415
| +132% | +$1.81M | 0.07% | 322 |
|
2020
Q4 | $1.38M | Sell |
4,870
-14,912
| -75% | -$4.23M | 0.03% | 550 |
|
2020
Q3 | $5.44M | Buy |
+19,782
| New | +$5.44M | 0.17% | 144 |
|
2020
Q1 | – | Sell |
-3,763
| Closed | -$566K | – | 1209 |
|
2019
Q4 | $566K | Buy |
3,763
+489
| +15% | +$73.6K | 0.02% | 735 |
|
2019
Q3 | $464K | Buy |
+3,274
| New | +$464K | 0.02% | 605 |
|